NCT05553834
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05553834
Title PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Duke University Durham North Carolina 27705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field